SCHEMBL641485

SCHEMBL641485

Cc1cc(S(=O)(=O)N2CCC[C@H]2CCCS(=O)(=O)N2CCN(C3CCN(C)CC3)CC2)c(C)cc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
HCRTR1 O43613 1/20 0.42
HCRTR2 O43614 1/20 0.42
HTR7 P34969 4/20 0.36
BDKRB1 P46663 3/20 0.36
HTR1A P08908 1/20 0.36
DRD2 P14416 1/20 0.36
HTR1D P28221 1/20 0.36
HTR1B P28222 1/20 0.36
HTR1E P28566 1/20 0.36
ADRA1B P35368 1/20 0.36
DRD3 P35462 1/20 0.36
TSHR P16473 2/20 0.35
TP53 P04637 1/20 0.35
EBP Q15125 1/20 0.34
DHCR7 Q9UBM7 1/20 0.34
MAPK1 P28482 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
EPHX2 P34913 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3340732 0.92 KMT2A (0.48) MEN1KMT2AHCRTR1HCRTR2HTR7
Hydrochloric Acid SCHEMBL641496 0.91 KMT2A (0.47) MEN1KMT2AHCRTR1HCRTR2HTR7
SCHEMBL640635 0.86 HTR7 (0.40) MEN1KMT2AHTR7HTR1ADRD2
SCHEMBL640634 0.86 HTR7 (0.40) MEN1KMT2AHTR7HTR1ADRD2
SCHEMBL639411 0.85 HTR7 (0.39) MEN1KMT2AHTR7HTR1ADRD2
SCHEMBL639412 0.85 HTR7 (0.39) MEN1KMT2AHTR7HTR1ADRD2
SCHEMBL10205740 0.85 KMT2A (0.55) MEN1KMT2AHCRTR1HCRTR2BDKRB1
SCHEMBL10205644 0.83 EBP (0.48) MEN1KMT2AHTR7HTR1ADRD2
SCHEMBL640203 0.83 CCR1 (0.44) MEN1KMT2AHTR7HTR1ADRD2
SCHEMBL640204 0.83 CCR1 (0.44) MEN1KMT2AHTR7HTR1ADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119805-B2 Substituted disulfonamide compounds GRUENENTHAL GMBH (DE) 2012-02-21 US claimed
US-20100152158-A1 Substituted Disulfonamide Compounds GRUENENTHAL GMBH (DE) 2010-06-17 US claimed
US-8119805-B2 Substituted disulfonamide compounds GRUENENTHAL GMBH (DE) 2012-02-21 US disclosed
US-8119805-B2 Substituted disulfonamide compounds GRUENENTHAL GMBH (DE) 2012-02-21 US disclosed
US-20100152158-A1 Substituted Disulfonamide Compounds GRUENENTHAL GMBH (DE) 2010-06-17 US disclosed
US-20100152158-A1 Substituted Disulfonamide Compounds GRUENENTHAL GMBH (DE) 2010-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152158-A1 Substituted Disulfonamide Compounds BDKRB1, BDKRB2, BRS3 MEN1 1203/4885KMT2A 2575/4885HCRTR1 567/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.